Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|October 21, 2019
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antiviralsMònica Pons, Sergio Rodríguez-Tajes, Juan Ignacio Esteban, et al.
Journal of Clinical Medicine|May 14, 2022
Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLDMònica Pons, Jesús Rivera-Esteban, Ramiro Manzano, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference LaboratoryIrene Belmonte, Alexa Nuñez, Miriam Barrecheguren, et al.
International Journal of Molecular Sciences|March 27, 2025
Harnessing Plasma Biomarkers to Predict Immunotherapy Outcomes in Hepatocellular Carcinoma: The Role of cfDNA, ctDNA, and CytokinesElena Vargas-Accarino, Mónica Higuera, María Bermúdez-Ramos, et al.
Respiratory Research|September 16, 2021
Association between circulating alpha-1 antitrypsin polymers and lung and liver diseaseAlexa Núñez, Irene Belmonte, Elena Miranda, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver diseaseSalvador Augustin, Mònica Pons, James B Maurice, et al.
Journal of Clinical Medicine|April 30, 2021
Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin DeficiencyMònica Pons, Alexa Núñez, Cristina Esquinas, et al.
BMJ Open|May 29, 2025
Prevalence of chronic wounds in hospitalised patients in Catalonia, Spain: a multicentre cross-sectional descriptive observational studyMaría Magdalena López-Jiménez, Marta Romero-García, Jordi Adamuz, et al.
Expert Review of Gastroenterology & Hepatology|July 8, 2025
Assessment and management of portal hypertension in patients with MASLD: advances and caveatsDiego Rojo, Alba Jiménez-Masip, Laura Pagès, et al.
Frontiers in Endocrinology|September 12, 2022
Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control studyJuan Bañares, Ramiro Manzano-Nuñez, Alba Prió, et al.
Pageof 4